What is it used for?
A 2ME test may be used to help:
Evaluate Brucella infection
The test can provide additional information when brucellosis is suspected based on symptoms, exposure history, and other laboratory findings.
Assess IgG antibody activity
Because 2-ME treatment reduces the contribution of IgM antibodies to the agglutination reaction, the test is traditionally used to assess the IgG component of Brucella antibodies.
Support evaluation of persistent or chronic brucellosis
IgG antibodies may remain detectable after an infection. Therefore, a positive 2-ME result can provide supportive information when evaluating patients with persistent or recurrent symptoms.
Monitor antibody levels
In some clinical settings, serial antibody titers may be used to monitor changes over time. However, antibody titers should not be used alone to determine whether treatment has been successful or whether active infection is present.
Why do I need a 2ME Test?
You may need a 2-ME test if your healthcare provider suspects brucellosis, particularly if you have symptoms such as:
Prolonged or recurrent fever
Excessive sweating
Fatigue
Headache
Muscle or joint pain
Back pain
Loss of appetite
Weight loss
Testing may be particularly relevant if you have had exposure to:
Unpasteurized milk or dairy products
Infected livestock or animals
Animal reproductive tissues or secretions
Occupational environments involving animals
Your provider may request the 2-ME test together with a Brucella standard agglutination test (SAT/Wright test) or other Brucella serological tests.
What happens during a 2ME Test?
The test requires a blood sample.
A healthcare professional will collect blood from a vein in your arm using a small needle.
The serum is separated from the blood and tested against Brucella antigen after treatment with 2-mercaptoethanol.
The laboratory determines the highest serum dilution that produces a significant agglutination reaction. This is reported as the 2-ME antibody titer.
Will I need to do anything to prepare for the test?
Usually, no fasting is required for a 2-ME blood test.
Follow any specific instructions provided by your healthcare provider or laboratory.
Tell your healthcare provider if you have previously been diagnosed or treated for brucellosis.
Are there any risks to the test?
There is very little risk associated with collecting the blood sample.
You may experience slight pain, bruising, or tenderness at the needle insertion site. These symptoms usually disappear quickly.
A positive 2-ME result
A positive result indicates that Brucella antibodies capable of agglutination after 2-ME treatment were detected.
This generally reflects the presence of IgG-associated antibody activity.
A positive result may support the diagnosis of brucellosis when the patient has compatible symptoms and an appropriate exposure history.
However, a positive result does not by itself prove active infection because Brucella antibodies can persist after previous infection.
A negative 2-ME result
A negative result means that significant agglutinating antibody activity was not detected under the test conditions used by the laboratory.
A negative result does not always completely exclude brucellosis, particularly if testing is performed early in the infection or if antibody levels are low.
Important note about 2ME Test results
The 2-ME titer should not be interpreted alone.
The result should be considered together with:
Brucella SAT/Wright titer
Patient's symptoms
Exposure history
Duration of illness
Previous history of brucellosis
Previous treatment
Other laboratory findings
When appropriate, blood culture or other microbiological testing
The specific titer considered clinically significant can vary according to the population, laboratory methodology, geographic region, and clinical setting. Therefore, laboratories should establish or follow appropriate interpretive criteria rather than applying a single universal cutoff.
A falling antibody titer over time may be supportive of a response to treatment, but serological titers alone should not be used as a definitive test of cure.
Important laboratory note: 2-ME testing is a traditional serological approach. Modern Brucella diagnosis should use the testing strategy recommended by the relevant clinical guidelines and laboratory, and serology should always be interpreted in the context of the patient's clinical presentation.
Prefer to talk to someone first? Contact us to book.
